The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Rheumatology Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
The global Rheumatology Therapeutics market size is expected to reach US$ 54090 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Rheumatology Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, are propelling Rheumatology Therapeutics market. Disease Modifying Anti-rheumatic Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nonsteroidal Anti-inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rheumatology Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rheumatology Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rheumatology Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rheumatology Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rheumatology Therapeutics covered in this report include Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer and Bristol-Myers Squibb Company, etc.
The global Rheumatology Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.
Global Rheumatology Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rheumatology Therapeutics market, Segment by Type:
Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others
Global Rheumatology Therapeutics market, by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Rheumatology Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Rheumatology Therapeutics market size is expected to reach US$ 54090 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Rheumatology Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, are propelling Rheumatology Therapeutics market. Disease Modifying Anti-rheumatic Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nonsteroidal Anti-inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rheumatology Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rheumatology Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rheumatology Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rheumatology Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rheumatology Therapeutics covered in this report include Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer and Bristol-Myers Squibb Company, etc.
The global Rheumatology Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.
Global Rheumatology Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rheumatology Therapeutics market, Segment by Type:
Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others
Global Rheumatology Therapeutics market, by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Rheumatology Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Rheumatology Therapeutics
1.1 Rheumatology Therapeutics Market Overview
1.1.1 Rheumatology Therapeutics Product Scope
1.1.2 Rheumatology Therapeutics Market Status and Outlook
1.2 Global Rheumatology Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Rheumatology Therapeutics Market Size by Region (2018-2029)
1.4 Global Rheumatology Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Rheumatology Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Rheumatology Therapeutics Market Size (2018-2029)
1.6.1 North America Rheumatology Therapeutics Market Size (2018-2029)
1.6.2 Europe Rheumatology Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Rheumatology Therapeutics Market Size (2018-2029)
1.6.4 Latin America Rheumatology Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Rheumatology Therapeutics Market Size (2018-2029)
2 Rheumatology Therapeutics Market by Type
2.1 Introduction
2.1.1 Disease Modifying Anti-rheumatic Drugs
2.1.2 Nonsteroidal Anti-inflammatory Drugs
2.1.3 Corticosteroids
2.1.4 Uric Acid Drugs
2.1.5 Others
2.2 Global Rheumatology Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Rheumatology Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Rheumatology Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Rheumatology Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Rheumatology Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Rheumatology Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Rheumatology Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Rheumatology Therapeutics Revenue Breakdown by Type (2018-2029)
3 Rheumatology Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Rheumatology Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Rheumatology Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Rheumatology Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Rheumatology Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Rheumatology Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Rheumatology Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Rheumatology Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Rheumatology Therapeutics Revenue Breakdown by Application (2018-2029)
4 Rheumatology Therapeutics Competition Analysis by Players
4.1 Global Rheumatology Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rheumatology Therapeutics as of 2022)
4.3 Date of Key Players Enter into Rheumatology Therapeutics Market
4.4 Global Top Players Rheumatology Therapeutics Headquarters and Area Served
4.5 Key Players Rheumatology Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Rheumatology Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Takeda Pharmaceutical
5.1.1 Takeda Pharmaceutical Profile
5.1.2 Takeda Pharmaceutical Main Business
5.1.3 Takeda Pharmaceutical Rheumatology Therapeutics Products, Services and Solutions
5.1.4 Takeda Pharmaceutical Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Takeda Pharmaceutical Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Rheumatology Therapeutics Products, Services and Solutions
5.2.4 Sanofi Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Genentech
5.3.1 Genentech Profile
5.3.2 Genentech Main Business
5.3.3 Genentech Rheumatology Therapeutics Products, Services and Solutions
5.3.4 Genentech Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Rheumatology Therapeutics Products, Services and Solutions
5.4.4 Novartis Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Janssen Biotech
5.5.1 Janssen Biotech Profile
5.5.2 Janssen Biotech Main Business
5.5.3 Janssen Biotech Rheumatology Therapeutics Products, Services and Solutions
5.5.4 Janssen Biotech Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Janssen Biotech Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Rheumatology Therapeutics Products, Services and Solutions
5.6.4 Amgen Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 AbbVie
5.7.1 AbbVie Profile
5.7.2 AbbVie Main Business
5.7.3 AbbVie Rheumatology Therapeutics Products, Services and Solutions
5.7.4 AbbVie Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Rheumatology Therapeutics Products, Services and Solutions
5.8.4 Pfizer Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Recent Developments
5.9 Bristol-Myers Squibb Company
5.9.1 Bristol-Myers Squibb Company Profile
5.9.2 Bristol-Myers Squibb Company Main Business
5.9.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Products, Services and Solutions
5.9.4 Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Bristol-Myers Squibb Company Recent Developments
5.10 Merck & Co.
5.10.1 Merck & Co. Profile
5.10.2 Merck & Co. Main Business
5.10.3 Merck & Co. Rheumatology Therapeutics Products, Services and Solutions
5.10.4 Merck & Co. Rheumatology Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Merck & Co. Recent Developments
6 North America
6.1 North America Rheumatology Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Rheumatology Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Rheumatology Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Rheumatology Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Rheumatology Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Rheumatology Therapeutics Market Dynamics
11.1 Rheumatology Therapeutics Industry Trends
11.2 Rheumatology Therapeutics Market Drivers
11.3 Rheumatology Therapeutics Market Challenges
11.4 Rheumatology Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
